Rebecca L. Qualy

发表

Growth hormone replacement therapy in adults with growth hormone deficiency improves maximal oxygen consumption independently of dosing regimen or physical activity.

A. Hoffman, A. Weltman, A. Zagar, 2008, The Journal of clinical endocrinology and metabolism.

Obesity Does Not Alter the Pharmacokinetics of Drotrecogin Alfa (Activated) in Severe Sepsis

R. Riker, J. Steingrub, D. Small, 2005, The Annals of pharmacotherapy.

CURB-65, PSI, and APACHE II to Assess Mortality Risk in Patients With Severe Sepsis and Community Acquired Pneumonia in PROWESS

C. Feldman, P. Laterre, G. Richards, 2011, Journal of intensive care medicine.

Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated)

P. Laterre, H. Levy, Rebecca L. Qualy, 2005, Critical care.

Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care

Joseph Johnston, J. Johnston, Mark D. Williams, 2004, Critical care.

Static and dynamic assessment of biomarkers in surgical patients with severe sepsis.

S. Lowry, D. Fry, H. Ford, 2004, Surgical infections.

Simplified Pharmacoeconomics of Critical Care and Severe Sepsis

F. Ernst, H. Levy, Rebecca L. Qualy, 2007, Journal of intensive care medicine.

Drotrecogin alfa (activated) treatment of older patients with severe sepsis.

G. Bernard, D. Angus, E. Ely, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Differences in follicle-stimulating hormone secretion between 45,X monosomy Turner syndrome and 45,X/46,XX mosaicism are evident at an early age.

J. Ross, C. Quigley, A. Zagar, 2006, The Journal of clinical endocrinology and metabolism.

A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: Comparison with a controlled clinical trial*

J. Jacobi, M. Zeckel, G. Schmidt, 2008, Critical care medicine.

From bench to bedside: a review of the clinical trial development plan of drotrecogin alfa (activated)

M. Short, Rebecca L. Qualy, D. Schlichting, 2006, Current medical research and opinion.

Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis.

P. Barie, S. Lowry, D. Fry, 2004, American journal of surgery.

Application of a population-based severity scoring system to individual patients results in frequent misclassification

Becky Bates, A. Shorr, F. Booth, 2005, Critical care.